SCHEMBL6604517

SCHEMBL6604517

Cc1nc(C(C)C)[nH]c1-c1ccnc(Nc2ccc(S(=O)(=O)NCC3CC3)cc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 10/20 0.44
CDK4 P11802 5/20 0.44
IKBKB O14920 5/20 0.42
STK4 Q13043 2/20 0.42
CNR1 P21554 2/20 0.42
CNR2 P34972 2/20 0.42
GSK3B P49841 2/20 0.40
CCNT1 O60563 1/20 0.40
CDK1 P06493 1/20 0.40
CCNB1 P14635 1/20 0.40
CSNK2A2 P19784 1/20 0.40
CCNA2 P20248 1/20 0.40
CCND1 P24385 1/20 0.40
CCNE1 P24864 1/20 0.40
CCND3 P30281 1/20 0.40
MAPK8 P45983 1/20 0.40
MAPK9 P45984 1/20 0.40
CSNK1A1 P48729 1/20 0.40
CSNK1D P48730 1/20 0.40
GSK3A P49840 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6603729 0.88 CDK2 (0.51) CDK2CDK4CCNA2CCNA1
SCHEMBL6606468 0.86 CDK2 (0.44) CDK2CDK4IKBKBSTK4CNR1
SCHEMBL6609742 0.84 CDK2 (0.63) CDK2CDK4IKBKBCDK1
SCHEMBL5108295 0.77 CDK2 (0.56) CDK2CDK4STK4GSK3BCCNT1
SCHEMBL6598505 0.77 CDK2 (0.72) CDK2CDK4GSK3BCCNT1CDK1
SCHEMBL6604144 0.76 CDK2 (0.55) CDK2CDK4IKBKBGSK3BCDK1
SCHEMBL6104318 0.75 CDK2 (0.71) CDK2CDK4STK4GSK3BCCNT1
SCHEMBL6604316 0.75 CDK2 (0.50) CDK2CDK4CCNA2CCNA1
SCHEMBL6103961 0.74 CDK2 (0.72) CDK2CDK4GSK3BCCNT1CDK1
SCHEMBL6605982 0.73 CDK2 (0.49) CDK2CDK4CCNA2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490354-A1 4-IMIDAZOLYL SUBSTITUTED PYRIMIDINE DERIVATIVES WITH CDK INHIBITORY ACTIVITY Astrazeneca AB (SE) 2004-12-29 EP claimed
WO-2003076434-A1 4- IMIDAZOLYL SUBSTUITED PYRIMIDINE DERIVATIVES WITH CDK INHIBITIORY ACTIVITY ASTRAZENECA AB (SE) 2003-09-18 WO claimed
EP-1490354-A1 4-IMIDAZOLYL SUBSTITUTED PYRIMIDINE DERIVATIVES WITH CDK INHIBITORY ACTIVITY Astrazeneca AB (SE) 2004-12-29 EP disclosed
WO-2003076434-A1 4- IMIDAZOLYL SUBSTUITED PYRIMIDINE DERIVATIVES WITH CDK INHIBITIORY ACTIVITY ASTRAZENECA AB (SE) 2003-09-18 WO disclosed